Eurofins BioPharma Services Newsletter 31 - February 2022
ARTICLES:
- Eurofins BPT Toronto expands psychedelics testing and certification services to support mental health therapies
- Eurofins CDMO helps solve the rising challenge of colon drug delivery for biologics
- Organoids: the next step in precision oncology
- The future of drug discovery: E3scanTM and beyond
- Eurofins BPT Italy expands biologics testing capacity with new fully operational BSL2 facility
- Eurofins Central Laboratory solves PBMC processing challenges in global clinical trials
Download the PDF version of pharma newsletter N°31
